LI
BDSI

Leap Investments’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Leap Investments’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,700
Closed -$82K – 657
2020
Q1 		$82K Sell
21,700
-97,897
-82% -$481K 0.12% 289
2019
Q4 		$756K Buy
119,597
+94,990
+386% +$558K 0.35% 86
2019
Q3 		$104K Buy
+24,607
New +$105K 0.05% 364

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Leap Investments's BDSI Position: Q2 2020 in Review

Leap Investments sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2020, closing a stake of 21,700 shares — an estimated $82K sold.

Leap Investments first reported a position in BDSI in Q3 2019 and held it in 3 quarters. The position peaked at $756K in Q4 2019. 158 funds tracked by Wall St. Rank hold BDSI as of Q2 2020.

  • Leap Investments reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2020 after selling out during the quarter.
  • Leap Investments sold 21,700 BioDelivery Sciences International, Inc. shares in Q2 2020, an estimated $82K.
  • Leap Investments first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 3 quarters.
  • Leap Investments's BioDelivery Sciences International, Inc. position peaked at $756K in Q4 2019.
  • 158 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.